SE7900798L - Sett att framstella ett immunpreparat for behandling av autoimmuna sjukdomar - Google Patents
Sett att framstella ett immunpreparat for behandling av autoimmuna sjukdomarInfo
- Publication number
- SE7900798L SE7900798L SE7900798A SE7900798A SE7900798L SE 7900798 L SE7900798 L SE 7900798L SE 7900798 A SE7900798 A SE 7900798A SE 7900798 A SE7900798 A SE 7900798A SE 7900798 L SE7900798 L SE 7900798L
- Authority
- SE
- Sweden
- Prior art keywords
- immune
- preparation
- treatment
- igg
- auto
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/65—Tetracyclines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
- A61K39/0258—Escherichia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
- A61K39/0266—Klebsiella
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
- A61K39/0275—Salmonella
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
- A61K39/0283—Shigella
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/05—Actinobacteria, e.g. Actinomyces, Streptomyces, Nocardia, Bifidobacterium, Gardnerella, Corynebacterium; Propionibacterium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/085—Staphylococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
- A61K39/092—Streptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/104—Pseudomonadales, e.g. Pseudomonas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Rheumatology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pain & Pain Management (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US87514078A | 1978-02-06 | 1978-02-06 |
Publications (2)
Publication Number | Publication Date |
---|---|
SE7900798L true SE7900798L (sv) | 1979-08-07 |
SE448344B SE448344B (sv) | 1987-02-16 |
Family
ID=25365266
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE7900798A SE448344B (sv) | 1978-02-06 | 1979-01-30 | Antikropp for behandling av reumatoid artrit samt sett att framstella denna |
Country Status (10)
Country | Link |
---|---|
JP (1) | JPS54113425A (sv) |
CH (1) | CH651210A5 (sv) |
DE (1) | DE2904044C2 (sv) |
DK (1) | DK158138C (sv) |
FR (1) | FR2416015A1 (sv) |
GB (1) | GB2013691B (sv) |
HK (1) | HK30283A (sv) |
IT (1) | IT1116524B (sv) |
NL (1) | NL7900766A (sv) |
SE (1) | SE448344B (sv) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4732757A (en) * | 1978-02-06 | 1988-03-22 | Stolle Research And Development Corporation | Prevention and treatment of rheumatoid arthritis |
USRE33565E (en) * | 1978-02-06 | 1991-04-02 | Stolle Research And Development Corporation | Prevention and treatment of rheumatioid arthritis |
WO1982002818A1 (en) * | 1981-02-26 | 1982-09-02 | Gani Mohamed Mutwahar | A process and apparatus for the recovery of immunoglobulins |
ATE16349T1 (de) * | 1981-04-28 | 1985-11-15 | Stolle Res & Dev | Verfahren zur herstellung einer entzuendungshemmenden rindermilch. |
JP2561234B2 (ja) * | 1981-05-12 | 1996-12-04 | スト−ル・リサ−チ・アンド・デイベロップメント・コ−ポレ−ション | 抗炎症剤 |
JPS58154513A (ja) * | 1982-03-09 | 1983-09-14 | Sendai Biseibutsu Kenkyusho | 予防及び治療薬 |
US4636384A (en) * | 1982-06-03 | 1987-01-13 | Stolle Research & Development Corporation | Method for treating disorders of the vascular and pulmonary systems |
ATE39842T1 (de) * | 1983-06-07 | 1989-01-15 | Stolle Res & Dev | Desodorant das bakterielle antikoerper enthaelt. |
JPS6112629A (ja) * | 1984-06-28 | 1986-01-21 | Lion Corp | 口腔内組成物 |
DE3785033T2 (de) * | 1987-07-21 | 1993-10-07 | Stolle Res & Dev | Verfahren zum Erhalten von immunregulierenden Faktoren mittels Säugetierimmunisierung. |
JP2664906B2 (ja) * | 1987-08-13 | 1997-10-22 | ストール・リサーチ・アンド・デイベロップメント・コーポレーション | 改良された哺乳類の免疫法 |
WO2000062806A1 (en) * | 1999-04-19 | 2000-10-26 | Richard Weisbart | Treatment of adult rheumatoid arthritis by oral administration of pooled human immunoglobulin and an antacid |
CA2423805A1 (en) * | 2000-09-28 | 2002-04-04 | Richard Weisbart | Treatment of immune-mediated diseases by oral administration of plasma fractions enriched in immunoglobulin g |
CA2437099A1 (en) * | 2001-01-30 | 2002-10-10 | The Lauridsen Group, Incorporated | Methods and compositions for treatment of immune dysfunction disorders |
AU2002309486A1 (en) * | 2001-01-30 | 2002-10-15 | The Lauridsen Group, Incorporated | Methods and compositions for modulating the immune system of animals |
JP4960632B2 (ja) * | 2006-01-10 | 2012-06-27 | 学校法人北里研究所 | 免疫ミルク組成物を有効成分とする単純ヘルペスウイルス感染症治療予防用組成物 |
JP5361132B2 (ja) * | 2006-03-10 | 2013-12-04 | 国立大学法人信州大学 | 免疫グロブリンgを含有する経口用免疫調節剤、その製造方法及び経口用免疫調節剤を配合してなる飲食品 |
JP2008179572A (ja) * | 2007-01-25 | 2008-08-07 | Shinshu Univ | 免疫グロブリンFcフラグメントレセプタータンパク及び/又は免疫グロブリンFcフラグメントレセプター様タンパク産生抑制剤及びその使用 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1155730A (en) * | 1965-10-24 | 1969-06-18 | Immune Milk Company Of America | Method of Producing Antitoxins |
DE1617769A1 (de) * | 1967-06-10 | 1971-04-01 | Rehm Eberhard | Verfahren zur Gewinnung von spezifischen Antikoerper enthaltender Milch und daraus hergestellter Praeparate |
JPS5136326A (ja) * | 1974-09-24 | 1976-03-27 | Komatsu Seiren Co | Seikeigorufubooru |
JPS5837285B2 (ja) * | 1975-05-29 | 1983-08-15 | カブシキガイシヤ ミドリジユウジ | チヨウナイカンセンシヨウチリヨウザイノセイゾウホウホウ |
JPS521014A (en) * | 1975-06-17 | 1977-01-06 | Stolle Res & Dev | Pharmaceutically acceptable carrier containing milk immunoglobulin |
JPS5381613A (en) * | 1976-12-28 | 1978-07-19 | Green Cross Corp:The | Remedies for enteral infection diseases |
CH627079A5 (en) * | 1977-04-15 | 1981-12-31 | Nestle Sa | Process for preparing a protein concentrate containing immunological factors of milk origin |
-
1979
- 1979-01-30 SE SE7900798A patent/SE448344B/sv not_active IP Right Cessation
- 1979-01-31 NL NL7900766A patent/NL7900766A/xx not_active Application Discontinuation
- 1979-02-02 DE DE2904044A patent/DE2904044C2/de not_active Expired
- 1979-02-02 GB GB7903836A patent/GB2013691B/en not_active Expired
- 1979-02-02 FR FR7902807A patent/FR2416015A1/fr active Granted
- 1979-02-05 JP JP1215279A patent/JPS54113425A/ja active Granted
- 1979-02-05 IT IT47888/79A patent/IT1116524B/it active
- 1979-02-06 DK DK049479A patent/DK158138C/da not_active IP Right Cessation
- 1979-02-06 CH CH1168/79A patent/CH651210A5/de not_active IP Right Cessation
-
1983
- 1983-08-25 HK HK302/83A patent/HK30283A/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
JPS54113425A (en) | 1979-09-05 |
DE2904044C2 (de) | 1986-02-06 |
GB2013691A (en) | 1979-08-15 |
DK158138B (da) | 1990-04-02 |
DK49479A (da) | 1979-08-07 |
FR2416015A1 (fr) | 1979-08-31 |
IT7947888A0 (it) | 1979-02-05 |
JPH0160455B2 (sv) | 1989-12-22 |
DK158138C (da) | 1990-08-27 |
NL7900766A (nl) | 1979-08-08 |
DE2904044A1 (de) | 1979-08-30 |
FR2416015B1 (sv) | 1983-06-17 |
CH651210A5 (de) | 1985-09-13 |
HK30283A (en) | 1983-09-02 |
SE448344B (sv) | 1987-02-16 |
IT1116524B (it) | 1986-02-10 |
GB2013691B (en) | 1982-08-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE7900798L (sv) | Sett att framstella ett immunpreparat for behandling av autoimmuna sjukdomar | |
US4748018A (en) | Method of passive immunization of mammals using avian antibody | |
Tsubokura et al. | Oral administration of antibodies as prophylaxis and therapy in Campylobacter jejuni‐infected chickens | |
Carlsson et al. | Secretory and serum immunoglobulin class-specific antibodies to poliovirus after vaccination | |
JPS5742629A (en) | Remedy for refractory diseases | |
Ogra | Mucosal immunity: Some historical perspective on host‐pathogen interactions and implications for mucosal vaccines | |
KR880003632A (ko) | 계란으로부터의 특이적항체함유재료 및 그 제조방법과 용도 | |
ES8802117A1 (es) | Un metodo para preparar una vacuna para inmunizacion contra enfermedades por bacterias gram-negativas | |
Boesman-Finkelstein et al. | Bovine lactogenic immunity against cholera toxin-related enterotoxins and Vibrio cholerae outer membranes | |
DK398683A (da) | Fremgangsmaade til fremstilling af antistoffer | |
US20070264264A1 (en) | Method and composition for conferring immunity in mammals | |
DE69823638D1 (de) | Oralprodukt zur Prävention und Behandlung von ansteckender Gastroenteritis in Kälbern | |
JP2912451B2 (ja) | ハチミツのワクチンとしての用途 | |
DE69813448D1 (de) | Biologisches Produkt zur präventiven oder therapeutischen oralen Verabreichung gegen Parvovirosis im Hund | |
CA2047843A1 (en) | Method and product for the treatment of gastric disease | |
Nathanson et al. | Cyclophosphamide-induced immunosuppression demonstrated in Pasteurella multocida-vaccinated chickens | |
Jackson et al. | Immune responses of rats to live Vibrio cholerae: secretion of antibodies in bile | |
Kaijser | Peroral Immunization of Healthy Adults with Live Escherichia coli O4K12 Bacteria: Antibody Response as Measured in Serum and Secretions | |
NO771289L (no) | Middel til profylaks og terapi av gastro-enteritis | |
RU2090193C1 (ru) | Способ получения специфического лактоглобулина | |
Reynolds et al. | Humoral immunity in the ewe 3. The influence of adjuvants and immunisation regimes on Immune reactivity in the breeding ewe and her progeny | |
Gordon et al. | Generation and characterization of IgY antibodies from Lohmann Brown hens immunized with Salmonella spp. for their subsequent application in nanotherapy | |
RU93052669A (ru) | Способ получения специфического лактоглобулина | |
RU2234267C2 (ru) | Способ вакцинопрофилактики эпидемического паротита на крайнем севере | |
Hanson et al. | Implications for Immunisation: The Milk IgA Antibody Response to Live and Inactivated Polio Virus Vaccines |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NAL | Patent in force |
Ref document number: 7900798-5 Format of ref document f/p: F |
|
NUG | Patent has lapsed |
Ref document number: 7900798-5 Format of ref document f/p: F |